Background: Accumulating evidence suggests that coronavirus disease 2019 (COVID-19) is
associated with hypercoagulative status, particularly for critically ill patients in the intensive …

There is controversial literature about the effects of the interleukin‐2 (IL‐2) cytokine family in
COVID‐19 pathogenesis and immunity. So we aimed to identify the potential in the role of …

Background: Many patients who have been suffering by Covid-19 suffer of long-Covid
syndrome, with symptoms of fatigue and muscular weakness that characterize post-acute …

Background A new clinical syndrome has been recognized following the COVID-19 vaccine,
termed thrombosis with thrombocytopenia syndrome (TTS). The following systematic review …

Background Some unanswered questions persist regarding the effectiveness of
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …

Introduction COVID-19 is associated to an increased risk of thrombosis, as a result of a
complex process that involves the activation of vascular and circulating cells, the release of …

Objectives To review current literature on the role of endothelial dysfunction in coronavirus
disease-2019 (COVID-19) infection in terms of pathophysiology, laboratory features and …

The coronavirus disease 2019 (COVID-19) pandemic has caused a devastating impact on
morbidity and mortality around the world. Severe acute respiratory syndrome-coronavirus-2 …

Severe forms of coronavirus 2019 (COVID-19) disease are caused by an exaggerated
systemic inflammatory response and subsequent inflammation-related coagulopathy. Anti …

Cortisol is a key element in acute stress including a severe infection. However, in
coronavirus-associated disease, 20% of subjects experience hypocortisolemia due to direct …